Tags

Type your tag names separated by a space and hit enter

Percutaneous excisional biopsy of clinically benign breast lesions with vacuum-assisted system: comparison of three devices.
Eur J Radiol. 2012 Apr; 81(4):725-30.EJ

Abstract

PURPOSE

The aim of this study was to compare three devices in percutaneous excisional biopsy of clinically benign breast lesions in terms of complete excision rate, duration of procedure and complications.

MATERIALS AND METHODS

In a retrospective study from March 2005 to May 2009, 983 lesions underwent ultrasound-guided excisional biopsy with three vacuum-assisted systems, respectively. The lesions were category 3 lesions as determined by ultrasound imaging according to Breast Imaging Reporting and Data System (BI-RADS) (n=951) or had been confirmed as benign by a previous core needle biopsy (n=32). The completely excision rate, duration of procedure and complications (hematoma, pain and ecchymosis) were recorded.

RESULTS

99.7% (980/983) lesions were demonstrated to be benign by pathology after percutaneous excisional biopsy. The overall complete excision rate was 94.8% (932/983). In lesions whose largest diameter equal to or larger than 1.5cm, the complete excision rates of EnCor(®) group (97.8%, 348/356) and Mammotome(®) group (97.2%, 139/143) were significantly higher than that of Vacora(®) group (91.9%, 445/484) (P<0.05). The EnCor(®) group (6.6±6.5min) had a significant less duration than Mammotome(®) (10.6±9.3min) and Vacora(®) group (25.6±23.3min) (P<0.05). Hematoma occurred more in EnCor(®) group and Mammotome(®) group than in Vacora(®) group (P<0.05).

CONCLUSIONS

All these three vacuum-assisted systems are highly successful for excisional biopsy of benign breast lesions.

Authors+Show Affiliations

Department of Ultrasound, Clinical Division of Iatrotechnique, Chinese People's Liberation Army General Hospital, 28 Fuxing Road, Beijing 100853, China. wzllg@sina.comNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Comparative Study
Journal Article

Language

eng

PubMed ID

21300503

Citation

Wang, Zhi Li, et al. "Percutaneous Excisional Biopsy of Clinically Benign Breast Lesions With Vacuum-assisted System: Comparison of Three Devices." European Journal of Radiology, vol. 81, no. 4, 2012, pp. 725-30.
Wang ZL, Liu G, Huang Y, et al. Percutaneous excisional biopsy of clinically benign breast lesions with vacuum-assisted system: comparison of three devices. Eur J Radiol. 2012;81(4):725-30.
Wang, Z. L., Liu, G., Huang, Y., Wan, W. B., & Li, J. L. (2012). Percutaneous excisional biopsy of clinically benign breast lesions with vacuum-assisted system: comparison of three devices. European Journal of Radiology, 81(4), 725-30. https://doi.org/10.1016/j.ejrad.2011.01.059
Wang ZL, et al. Percutaneous Excisional Biopsy of Clinically Benign Breast Lesions With Vacuum-assisted System: Comparison of Three Devices. Eur J Radiol. 2012;81(4):725-30. PubMed PMID: 21300503.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Percutaneous excisional biopsy of clinically benign breast lesions with vacuum-assisted system: comparison of three devices. AU - Wang,Zhi Li, AU - Liu,Gang, AU - Huang,Yan, AU - Wan,Wen Bo, AU - Li,Jun Lai, Y1 - 2011/02/05/ PY - 2010/12/28/received PY - 2011/01/03/accepted PY - 2011/2/9/entrez PY - 2011/2/9/pubmed PY - 2012/7/17/medline SP - 725 EP - 30 JF - European journal of radiology JO - Eur J Radiol VL - 81 IS - 4 N2 - PURPOSE: The aim of this study was to compare three devices in percutaneous excisional biopsy of clinically benign breast lesions in terms of complete excision rate, duration of procedure and complications. MATERIALS AND METHODS: In a retrospective study from March 2005 to May 2009, 983 lesions underwent ultrasound-guided excisional biopsy with three vacuum-assisted systems, respectively. The lesions were category 3 lesions as determined by ultrasound imaging according to Breast Imaging Reporting and Data System (BI-RADS) (n=951) or had been confirmed as benign by a previous core needle biopsy (n=32). The completely excision rate, duration of procedure and complications (hematoma, pain and ecchymosis) were recorded. RESULTS: 99.7% (980/983) lesions were demonstrated to be benign by pathology after percutaneous excisional biopsy. The overall complete excision rate was 94.8% (932/983). In lesions whose largest diameter equal to or larger than 1.5cm, the complete excision rates of EnCor(®) group (97.8%, 348/356) and Mammotome(®) group (97.2%, 139/143) were significantly higher than that of Vacora(®) group (91.9%, 445/484) (P<0.05). The EnCor(®) group (6.6±6.5min) had a significant less duration than Mammotome(®) (10.6±9.3min) and Vacora(®) group (25.6±23.3min) (P<0.05). Hematoma occurred more in EnCor(®) group and Mammotome(®) group than in Vacora(®) group (P<0.05). CONCLUSIONS: All these three vacuum-assisted systems are highly successful for excisional biopsy of benign breast lesions. SN - 1872-7727 UR - https://www.unboundmedicine.com/medline/citation/21300503/Percutaneous_excisional_biopsy_of_clinically_benign_breast_lesions_with_vacuum_assisted_system:_comparison_of_three_devices_ L2 - https://linkinghub.elsevier.com/retrieve/pii/S0720-048X(11)00088-X DB - PRIME DP - Unbound Medicine ER -